MBOTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Microbot Medical Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.95+0.00 (+0.29%)
Close on Oct 19, 2026
- Market cap
- $63.99M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.8072 (−65.48%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $63.99M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.93
- Dividend yield
- –
- Free cash flow yield
- -28.02%
Fundamentals
- Net income
- -$16.34M
- EPS, diluted
- -$0.25
- Free cash flow
- -$17.93M
- Book value per share
- $1.03
- Diluted shares
- 67M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$18.51M
Net income
-$16.34M
EPS, diluted
-$0.25
Free cash flow
-$17.93M
Reported periodTrailing twelve months